These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18575157)

  • 1. Effect of atorvastatin on bone mineral density in patients with acute coronary syndrome.
    Pérez-Castrillón JL; Abad L; Vega G; Sanz-Cantalapiedra A; García-Porrero M; Pinacho F; Dueñas A
    Eur Rev Med Pharmacol Sci; 2008; 12(2):83-8. PubMed ID: 18575157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome.
    Pérez-Castrillón JL; Vega G; Abad L; Sanz-Cantalapiedra A; Gonzalez Sagredo M; de Luis D; Duenas-Laita A
    Ann Nutr Metab; 2008; 53(2):117-21. PubMed ID: 18997459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease.
    Pérez-Castrillón JL; Vega G; Abad L; Sanz A; Chaves J; Hernandez G; Dueñas A
    Am J Cardiol; 2007 Apr; 99(7):903-5. PubMed ID: 17398180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atorvastatin on bone metabolism and bone mineral density in Wistar rats.
    Chang B; Yang J; Li H; Lu S; Chen L; Fang P
    Pharmazie; 2011 Jul; 66(7):535-7. PubMed ID: 21812330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (TTA)n polymorphism in 3-hydroxy-3-methylglutaryl-coenzyme A and response to atorvastatin in coronary artery disease patients.
    Noriega V; Pennanen C; Sánchez MP; Chiong M; Llancaqueo M; Lavandero S; Prieto JC
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):211-5. PubMed ID: 19067673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiplatelet effect of atorvastatin in patients with acute coronary syndrome depends on the hs-CRP level.
    Vasilieva E; Kasyanova O; Shpektor A
    Acute Card Care; 2008; 10(3):181-4. PubMed ID: 18608041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of DKK1 in patients with acute myocardial infarction and response to atorvastatin.
    Pérez Castrillón JL; San Miguel A; Vega G; Abad L; Andres Domingo M; Gonzalez Sagredo M; de Luis D; Duenas-Laita A
    Int J Cardiol; 2010 Nov; 145(1):164-5. PubMed ID: 19720407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
    Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP; Peng DQ; Yu BL; Huo Y;
    Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence.
    Schwartz JB
    Clin Pharmacol Ther; 2009 Feb; 85(2):198-203. PubMed ID: 18754003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study).
    Tung P; Wiviott SD; Cannon CP; Murphy SA; McCabe CH; Gibson CM
    Am J Cardiol; 2009 Apr; 103(8):1056-60. PubMed ID: 19361589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.
    Gómez-Hernández A; Sánchez-Galán E; Ortego M; Martín-Ventura JL; Blanco-Colio LM; Tarín-Vicente N; Jiménez-Nacher JJ; López-Bescos L; Egido J; Tuñón J
    Am J Cardiol; 2008 Jul; 102(1):12-8. PubMed ID: 18572029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G; Charra B; Chazot C
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study.
    Malik P; Gasser RW; Kemmler G; Moncayo R; Finkenstedt G; Kurz M; Fleischhacker WW
    Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: a 1-year randomized trial.
    Chen ZG; Cai HJ; Jin X; Lu JH; Wang J; Fang NY
    Arch Gerontol Geriatr; 2014; 59(3):515-21. PubMed ID: 25131773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.